Sector consensus Grifols, S.A.

Equities

Market Closed - BME Other stock markets 16:35:01 14/07/2025 BST			After hours 20:21:37
11.65 ^EUR	+0.26%		11.59	-0.53%

07-10	European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	MT
07-10	Grifols, S.A., 2024 Earnings Call, Feb 26, 2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Ecart obj. / dr	Nbr of analysts
GRIFOLS, S.A.			€15.96	+37.33%	13
CSL LIMITED			A$201.38	+27.15%	17
REGENERON PHARMACEUTICALS, INC.			US$728.55	+28.32%	24
SAMSUNG BIOLOGICS CO.,LTD.			₩1,318,038.46	+24.7%	26
UCB			€212.29	+24.18%	17
BIOGEN INC.			US$172.25	+28.34%	31
INNOVENT BIOLOGICS, INC.			HK$75.97	+3.28%	27
ALTEOGEN INC.			₩565,000	+28.7%	2
INTRA-CELLULAR THERAPIES, INC.	-	-	-	-	-
INCYTE CORPORATION			US$75.41	+9.94%	23
MODERNA, INC.			US$47.59	+41.47%	22
BIOMARIN PHARMACEUTICAL INC.			US$95.52	+64.4%	28
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	CN¥53.1	-10.76%	1
SWEDISH ORPHAN BIOVITRUM AB			SEK 344.33	+20.48%	12
BRIDGEBIO PHARMA, INC.			US$61.14	+31.57%	21
3SBIO INC.			HK$20	-12.91%	10
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.			CN¥29.73	+44.76%	6
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.		-	CN¥6.2	-10.4%	1
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.			CN¥107.17	+5.06%	2
Average			104,738.06	+21.42%	16
Weighted average by Cap.			212,292.76	+24.39%	19